Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Tecarfarin (formerly ATI-5923)
print preview
bookmark
share with colleague
General Information
Company
Armetheon Inc.
Description
Long-acting inhibitor of vitamin K epoxide reductase (VKOR)
Molecular Target
Vitamin K epoxide reductase complex subunit 1 (VKORC1)
Mechanism of Action
Latest Stage of Development
Phase II/III
Indication
Blood clots
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information